Page 31 - Read Online
P. 31

Soren et al. Cancer Drug Resist 2020;3:18-25                                      Cancer
               DOI: 10.20517/cdr.2019.106                                            Drug Resistance




               Review                                                                        Open Access


               Topoisomerase IB: a relaxing enzyme for stressed
               DNA


               Bini Chhetri Soren , Jagadish Babu Dasari , Alessio Ottaviani , Federico Iacovelli , Paola Fiorani 1,2
                                                     1,#
                                1
                                                                      2
                                                                                        1
               1 Department of Biology, University of Rome Tor Vergata, Rome 00133, Italy.
               2 Institute of Translational Pharmacology, National Research Council, Rome 00133, Italy.
               # Present address: Department of Research and Application Development, Biogenex Life Sciences, Telangana 501510, India.
               Correspondence to: Dr. Paola Fiorani, Institute of Translational Pharmacology, National Research Council, CNR, Via Del
               Fosso del Cavaliere 100, Rome 00133, Italy. E-mail: paola.fiorani@uniroma2.it
               How to cite this article: Soren BC, Dasari JB, Ottaviani A, Iacovelli F, Fiorani P. Topoisomerase IB: a relaxing enzyme for
               stressed DNA. Cancer Drug Resist 2020;3:18-25. http://dx.doi.org/10.20517/cdr.2019.106

               Received: 5 Nov 2019    First Decision: 3 Dec 2019    Revised: 10 Dec 2019     Accepted: 18 Dec 2019    Published: 19 Mar 2020

               Science Editor: Robert C. A. M. van Waardenburg    Copy Editor: Cai-Hong Wang    Production Editor: Tian Zhang


               Abstract
               DNA topoisomerase I enzymes relieve the torsional strain in DNA; they are essential for fundamental molecular
               processes such as DNA replication, transcription, recombination, and chromosome condensation; and act by cleaving
               and then religating DNA strands. Over the past few decades, scientists have focused on the DNA topoisomerases
               biological functions and established a unique role of Type I DNA topoisomerases in regulating gene expression and DNA
               chromosome condensation. Moreover, the human enzyme is being investigated as a target for cancer chemotherapy.
               The active site tyrosine is responsible for initiating two transesterification reactions to cleave and then religate the DNA
               backbone, allowing the release of superhelical tension. The different steps of the catalytic mechanism are affected by
               various inhibitors; some of them prevent the interaction between the enzyme and the DNA while others act as poisons,
               leading to TopI-D NA lesions, breakage of DNA, and eventually cellular death. In this review, our goal is to provide an
               overview of mechanism of human topoisomerase IB action together with the different types of inhibitors and their effect
               on the enzyme functionality.


               Keywords: Human DNA topoisomerase IB, mechanism of action, drugs inhibition





               DNA TOPOISOMERASE I
               Topoisomerase I (TopI) is a class of enzymes responsible for catalyzing the relaxation of supercoiled DNA
               during cell essential processes such as DNA replication, transcription, recombination, and chromosome
                           [1,2]
               condensation . TopI enzymes are not dependent on ATP for their catalytic activity, except for reverse
                           © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                    www.cdrjournal.com
   26   27   28   29   30   31   32   33   34   35   36